Trial Profile
Clinical Trials Insight: 700043112
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2009
Price :
$35
*
At a glance
- Drugs Prostate cancer DNA vaccine (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Merck & Co
- 07 Apr 2009 New trial record.